HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsuhide Naruse Selected Research

Hyperaldosteronism (Conn Syndrome)

11/2022Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study.
10/2022Association of achieved blood pressure after treatment for primary aldosteronism with long-term kidney function.
4/2022Primary aldosteronism with mild autonomous cortisol secretion increases renal complication risk.
1/2022Novel chemiluminescent immunoassay to measure plasma aldosterone and plasma active renin concentrations for the diagnosis of primary aldosteronism.
1/2022Association of cardiovascular disease risk and changes in renin levels by mineralocorticoid receptor antagonists in patients with primary aldosteronism.
1/2022Feasibility of Imaging-Guided Adrenalectomy in Young Patients With Primary Aldosteronism.
11/2021Subtype-specific trends in the clinical picture of primary aldosteronism over a 13-year period.
1/2021Sex Differences in Renal Outcomes After Medical Treatment for Bilateral Primary Aldosteronism.
1/2021Adrenal Venous Sampling-Guided Adrenalectomy Rates in Primary Aldosteronism: Results of an International Cohort (AVSTAT).
1/2021Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsuhide Naruse Research Topics

Disease

49Hyperaldosteronism (Conn Syndrome)
11/2022 - 06/2003
23Adenoma (Adenomas)
01/2022 - 06/2003
22Hypertension (High Blood Pressure)
11/2022 - 10/2002
14Neoplasms (Cancer)
12/2021 - 01/2005
13Paraganglioma (Paragangliomas)
12/2021 - 01/2009
10Pheochromocytoma
12/2021 - 01/2009
8Cushing Syndrome
01/2022 - 02/2004
6Hypokalemia
10/2021 - 01/2014
5Neoplasm Metastasis (Metastasis)
10/2021 - 02/2006
4Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 08/2004
4Hyperplasia
11/2021 - 02/2004
3Diabetes Mellitus
10/2019 - 01/2009
3Dyslipidemias (Dyslipidemia)
12/2018 - 08/2008
3Hashimoto Disease (Thyroiditis, Hashimoto)
01/2015 - 01/2010
3Thyrotoxicosis
01/2012 - 08/2007
3Pituitary Neoplasms (Pituitary Adenoma)
09/2011 - 01/2005
3Fibrosis (Cirrhosis)
09/2009 - 10/2002
3Stroke (Strokes)
11/2004 - 07/2002
2Chronic Renal Insufficiency
10/2022 - 11/2014
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2020 - 07/2002
2Proteinuria
10/2019 - 09/2019
2Adrenocortical Adenoma (Disease, Conn's)
07/2019 - 01/2015
2Type 2 Diabetes Mellitus (MODY)
01/2019 - 01/2003
2Essential Hypertension
01/2019 - 01/2018
2Graves Disease (Basedow Disease)
01/2012 - 03/2007
2Thyroid Neoplasms (Thyroid Cancer)
01/2012 - 12/2007
2Pancreatitis
11/2010 - 05/2007
2Hyperalgesia
11/2010 - 05/2007
2Pain (Aches)
11/2010 - 05/2007
2Body Weight (Weight, Body)
02/2009 - 05/2004
2Confusion (Bewilderment)
06/2007 - 06/2004
1AIDS-Related Complex (ARC)
01/2022
1Metabolic Bone Diseases (Osteopenia)
01/2022
1Osteoporosis
01/2022
1Ganglion Cysts (Ganglion)
06/2020
1Carcinoma (Carcinomatosis)
06/2020
1Neuroblastoma
06/2020
1Insulin Resistance
01/2019
1Prediabetic State (Prediabetes)
01/2019

Drug/Important Bio-Agent (IBA)

42AldosteroneIBA
01/2022 - 07/2002
12Hydrocortisone (Cortisol)FDA LinkGeneric
04/2022 - 06/2004
12Adrenocorticotropic Hormone (ACTH)FDA Link
03/2020 - 02/2004
10ReninIBA
01/2022 - 06/2003
9Mineralocorticoid Receptor AntagonistsIBA
10/2022 - 07/2002
7CatecholaminesIBA
12/2021 - 07/2012
5Antihypertensive Agents (Antihypertensives)IBA
11/2022 - 01/2019
5Spironolactone (Aldactone)FDA LinkGeneric
01/2021 - 07/2002
5PotassiumIBA
10/2019 - 12/2007
4Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2021 - 01/2009
4Cytochrome P-450 CYP11B2 (CYP11B2)IBA
07/2019 - 04/2013
4Dexamethasone (Maxidex)FDA LinkGeneric
01/2019 - 06/2004
4Angiotensin Receptor AntagonistsIBA
01/2019 - 07/2002
4Messenger RNA (mRNA)IBA
09/2009 - 07/2002
3EnzymesIBA
01/2022 - 01/2021
3Eplerenone (Inspra)FDA LinkGeneric
01/2021 - 08/2004
3Cosyntropin (Cortrosyn)FDA LinkGeneric
03/2020 - 02/2017
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2019 - 01/2003
3Dacarbazine (DIC)FDA LinkGeneric
01/2017 - 07/2012
3Hormones (Hormone)IBA
01/2014 - 08/2004
3candesartanIBA
11/2004 - 07/2002
2Pharmaceutical PreparationsIBA
11/2022 - 01/2014
2AntibodiesIBA
12/2021 - 03/2014
2alpha-Methyltyrosine (Metirosine)FDA Link
12/2019 - 03/2018
2Telmisartan (Micardis)FDA Link
01/2019 - 02/2009
2SteroidsIBA
01/2018 - 08/2004
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2017 - 04/2013
2Vincristine (Oncovin)FDA LinkGeneric
01/2017 - 04/2013
2Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA
01/2017 - 04/2013
2SodiumIBA
06/2014 - 12/2007
2CalciumIBA
01/2014 - 12/2007
2Nonsense Codon (Nonsense Mutation)IBA
01/2013 - 08/2009
2Methimazole (Thiamazole)FDA LinkGeneric
01/2012 - 03/2007
2Thyrotropin Receptors (Thyrotropin Receptor)IBA
01/2012 - 12/2007
2Peptide Hydrolases (Proteases)FDA Link
11/2010 - 05/2007
2CeruletideIBA
11/2010 - 05/2007
2Thyroxine (Levothyroxine)FDA LinkGeneric
01/2010 - 08/2007
1ferriteIBA
01/2022
1Monoclonal AntibodiesIBA
01/2022
1Dopamine beta-HydroxylaseIBA
12/2021
1Choline O-Acetyltransferase (Choline Acetyltransferase)IBA
12/2021
1Acetylcholine (Acetylcholine Chloride)FDA Link
12/2021
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
12/2021
13-Iodobenzylguanidine (Iobenguane)IBA
10/2021
1CreatinineIBA
01/2021
1Gonadal Steroid Hormones (Sex Hormones)IBA
06/2020
1AntigensIBA
06/2020
1BuffersIBA
06/2020
1ParaffinIBA
06/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2019
1Angiotensin II Type 1 Receptor BlockersIBA
01/2019
1azilsartanIBA
01/2019
1DiureticsIBA
01/2019
1MineralsIBA
01/2019
1Triglycerides (Triacylglycerol)IBA
12/2018

Therapy/Procedure

24Adrenalectomy
11/2022 - 01/2008
8Therapeutics
10/2020 - 07/2002
4Aftercare (After-Treatment)
10/2022 - 01/2019
3Drug Therapy (Chemotherapy)
01/2017 - 07/2012
2Combination Drug Therapy (Combination Chemotherapy)
01/2017 - 04/2013
1Cystectomy
03/2020